Jinyu Bio-Technology Co Ltd
SSE:600201
Jinyu Bio-Technology Co Ltd
Net Income (Common)
Jinyu Bio-Technology Co Ltd
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
J
|
Jinyu Bio-Technology Co Ltd
SSE:600201
|
Net Income (Common)
¥288.9m
|
CAGR 3-Years
2%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
2%
|
Beigene Ltd
HKEX:6160
|
Net Income (Common)
-¥13.6B
|
CAGR 3-Years
-25%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Innovent Biologics Inc
HKEX:1801
|
Net Income (Common)
-¥1B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
29%
|
CAGR 10-Years
N/A
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Net Income (Common)
¥1.2B
|
CAGR 3-Years
23%
|
CAGR 5-Years
34%
|
CAGR 10-Years
N/A
|
|
S
|
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
|
Net Income (Common)
¥2.1B
|
CAGR 3-Years
23%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
24%
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Net Income (Common)
¥8.5B
|
CAGR 3-Years
40%
|
CAGR 5-Years
47%
|
CAGR 10-Years
45%
|
See Also
What is Jinyu Bio-Technology Co Ltd's Net Income (Common)?
Net Income (Common)
288.9m
CNY
Based on the financial report for Sep 30, 2023, Jinyu Bio-Technology Co Ltd's Net Income (Common) amounts to 288.9m CNY.
What is Jinyu Bio-Technology Co Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
2%
Over the last year, the Net Income (Common) growth was 66%. The average annual Net Income (Common) growth rates for Jinyu Bio-Technology Co Ltd have been 2% over the past three years , -20% over the past five years , and 2% over the past ten years .